Plasma Leptin Is Elevated in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Cao, Mengshu ^a   Swigris, Jeffery J ^b   Wang, Xin ^a   Cao, Min ^a   Qiu, Yuying ^a   Huang, Mei ^a   Xiao, Yonglong ^a   Cai, Hourong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARBOHYDRATE ANTIGEN; KREBS VON DEN LUNGEN 6; LACTATE DEHYDROGENASE; LEPTIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MUC1 PROTEIN, HUMAN; MUCIN 1;

ACUTE DISEASE; ADULT; BODY MASS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE EXACERBATION; FEMALE; FIBROSING ALVEOLITIS; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PREDICTION; RESPIRATORY TRACT PARAMETERS; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL; SURVIVOR; BLOOD; KAPLAN MEIER METHOD; METABOLISM; PATHOLOGY; PROPORTIONAL HAZARDS MODEL;

BIOMARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN-MEIER ESTIMATE; LEPTIN; MALE; MIDDLE AGED; MUCIN-1; PROPORTIONAL HAZARDS MODELS;

EID: 84985920584     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/6940480     Document Type: Review

References (28)

1. G. Raghu, H. R. Collard, J. J. Egan et al., "An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidencebased guidelines for diagnosis and management," American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 6, pp. 788-824, 2011.
2. H. R. Collard, B. B. Moore, K. R. Flaherty et al., "Acute exacerbations of idiopathic pulmonary fibrosis," American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 7, pp. 636-643, 2007.
3. K. A. Johannson and H. R. Collard, "Acute exacerbation of idiopathic pulmonary fibrosis: a proposal," Current Respiratory Care Reports, vol. 2, no. 4, pp. 233-240, 2013.
4. J.W. Song, S.-B. Hong, C.-M. Lim, Y. Koh, and D. S. Kim, "Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome," European Respiratory Journal, vol. 37, no. 2, pp. 356-363, 2011.
5. A. Yokoyama, N. Kohno, H. Hamada et al., "Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis," American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 5, pp. 1680-1684, 1998.
6. H. Ohnishi, A. Yokoyama, K. Kondo et al., "Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases," American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 3, pp. 378-381, 2002.
7. R. A. DeRemee, "Serum lactic dehydrogenase activity and diffuse interstitial pneumonitis," Journal of the American Medical Association, vol. 204, no. 13, pp. 1193-1195, 1968.
8. H. Takahashi, T. Fujishima, H. Koba et al., "Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent," American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 3, part 1, pp. 1109-1114, 2000.
9. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman, "Positional cloning of the mouse obese gene and its human homologue," Nature, vol. 372, no. 6505, pp. 425-432, 1994.
10. H. Masuzaki, Y. Ogawa, N. Sagawa et al., "Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans," Nature Medicine, vol. 3, no. 9, pp. 1029-1033, 1997.
11. H. Chen, O. Charlat, L. A. Tartaglia et al., "Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice," Cell, vol. 84, no. 3, pp. 491-495, 1996.
12. G. Frühbeck, "Intracellular signalling pathways activated by leptin," Biochemical Journal, vol. 393, no. 1, pp. 7-20, 2006.
13. F. Malli, A. I. Papaioannou, K. I. Gourgoulianis, and Z. Daniil, "The role of leptin in the respiratory system: an overview," Respiratory Research, vol. 11, article 152, 2010.
14. E. Elinav, M. Ali, R. Bruck et al., "Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function," Hepatology, vol. 49, no. 1, pp. 278-286, 2009.
15. P. Fernández-Riejos, S. Najib, J. Santos-Alvarez et al., "Role of leptin in the activation of immune cells," Mediators of Inflammation, vol. 2010, Article ID 568343, 8 pages, 2010.
16. S. Ziai, L. Belson, A. Malet et al., "Theassociation between leptin and insulin levels in adults with cystic fibrosis," Diabetes and Metabolism, vol. 38, no. 1, pp. 34-39, 2012.
17. A. Bellmeyer, J. M. Martino, N. S. Chandel, G. R. S. Budinger, D. A. Dean, and G. M. Mutlu, "Leptin resistance protects mice from hyperoxia-induced acute lung injury," American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 6, pp. 587-594, 2007.
18. M. Jain, G. R. S. Budinger, A. Lo et al., "Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-γ," American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 11, pp. 1490-1498, 2011.
19. T.-C. Lin, T.-C. Lee, S.-L. Hsu, and C.-S. Yang, "The molecular mechanism of leptin secretion and expression induced by aristolochic acid in kidney fibroblast," PLoS ONE, vol. 6, no. 2, Article ID e16654, 2011.
20. A.-H. Yang, S.-W. Huang, J.-Y. Chen, J.-K. Lin, and C.-Y. Chen, "Leptin augments myofibroblastic conversion and fibrogenic activity of human peritoneal mesothelial cells: a functional implication for peritoneal fibrosis," Nephrology Dialysis Transplantation, vol. 22, no. 3, pp. 756-762, 2007.
21. J. Kobayashi, Y. Itoh, S. Kitamura, and T. Kawai, "Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia," Rinsho Byori, vol. 44, no. 7, pp. 653-658, 1996.
22. W. D. Travis, U. Costabel, D.M. Hansell et al., "An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias," American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 6, pp. 733-748, 2013.
23. S. S. Choi, W.-K. Syn, G. F. Karaca et al., "Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the Hedgehog pathway," The Journal of Biological Chemistry, vol. 285, no. 47, pp. 36551-36560, 2010.
24. S. Manolakopoulos, S. Bethanis, C. Liapi et al., "An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study," BMC Gastroenterology, vol. 7, article 17, 2007.
25. R. P. Myers, D. Messous, T. Poynard, and F. Imbert-Bismut, "Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis C," Canadian Journal of Gastroenterology, vol. 21, no. 5, pp. 289-294, 2007.
26. P. Kythreotis, A. Kokkini, S. Avgeropoulou et al., "Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary disease," BMC Pulmonary Medicine, vol. 9, article 11, 2009.
27. E. C. Creutzberg, E. F. M. Wouters, I. M. L. Vanderhoven-Augustin, M. A. Dentener, and A. M.W. J. Schols, "Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease," American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 4, part 1, pp. 1239-1245, 2000.
28. N. Ishikawa, N. Hattori, A. Yokoyama, and N. Kohno, "Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases," Respiratory Investigation, vol. 50, no. 1, pp. 3-13, 2012.